Arama Sonuçları - Tomomi W. Nobashi
- Gösterilen 1 - 6 sonuçlar arası kayıtlar. 6
-
1
ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy Yazar: Zunyu Xiao, Aaron T. Mayer, Tomomi W. Nobashi, Sanjiv S. Gambhir
Baskı/Yayın Bilgisi 2020Carta -
2
CT-ORG, a new dataset for multiple organ segmentation in computed tomography Yazar: Blaine Rister, Darvin Yi, Kaushik Shivakumar, Tomomi W. Nobashi, Daniel L. Rubin
Baskı/Yayın Bilgisi 2020Artigo -
3
<sup>18</sup>F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease Yazar: Tomomi W. Nobashi, Takeshi Kubo, Yuji Nakamoto, Tomohiro Handa, Sho Koyasu, Takayoshi Ishimori, Michiaki Mishima, Kaori Togashi
Baskı/Yayın Bilgisi 2016Artigo -
4
-
5
Comparison of 3 Interpretation Criteria for <sup>68</sup>Ga-PSMA11 PET Based on Inter- and Intrareader Agreement Yazar: Akira Toriihara, Tomomi W. Nobashi, Lucia Baratto, Heying Duan, Farshad Moradi, Sonya Park, Negin Hatami, Carina Marí Aparici, Guido Davidzon, Andrei Iagaru
Baskı/Yayın Bilgisi 2019Artigo -
6
Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers Yazar: Tomomi W. Nobashi, Yuko Nishimoto, Yujiro Kawata, Hidetaka Yutani, Masaki Nakamura, Yuichi Tsuji, Atsushi Yoshida, Akihiko Sugimoto, Takayuki Yamamoto, Israt S. Alam, Satoshi Noma
Baskı/Yayın Bilgisi 2020Artigo
Arama Araçları:
İlgili Konular
Internal medicine
Medicine
Adverse effect
Cancer
Gastroenterology
Immunology
Lung
Nuclear medicine
Annotation
Arthritis
Artificial intelligence
Artificial neural network
Biochemical recurrence
Bronchiectasis
Cancer immunotherapy
Cancer research
Code (set theory)
Complication
Computer science
Concordance
DLCO
Diffusing capacity
Disease
Generalization
Glutamate carboxypeptidase II
Idiopathic pulmonary fibrosis
Image segmentation
Immune system
Immunotherapy
Interstitial lung disease